Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Ex vivo heart perfusion
FY 2015-16
Summary
Heart transplantation is a viable therapeutic option for patients suffering end stage heart diseases. However there is a shortage of viable donor hearts due to size limitations and lack of brain death donors (the standard criteria for organ donation). One strategy to increase the donor pool is extending the criteria to include those donated after “cardiocirculatory determination of death” (DCD). However DCD donor hearts are considered suboptimal and need resuscitation.
Ex vivo heart perfusion (EVHP) has been proposed as a method for preservation, resuscitation, and evaluation of the donor heart, replacing conventional cold static storage. In EVHP, the heart is perfused and preserved in a beating status under normal physiological temperature and conditions. Unlike cold static storage, EVHP provides the opportunity of functional assessment and potential resuscitation and recovery of damaged DCD hearts before transplantation.
Due to the high metabolic demands of the working heart, EVHP requires the use of an oxygen carrier in the perfusate. We aim to study the effects of different oxygen carriers in the perfusate during EVHP resuscitation of hearts in the porcine model. Donor blood and bank blood are suboptimal due to immune and electrolyte factors. Cell-free hemoglobin-based oxygen carriers are an attractive option due to various immune and logistical advantages, but they can cause oxidative stress. Antioxidants and nitric oxide donors have been proposed as a solution to the problem, but they have yet to be studied systematically in the context of EVHP.
If our findings can be translated into a clinical protocol, the heart transplant donor pool could increase drastically, saving lives of many patients with end stage heart disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
354500
Name
Wu Yilun
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Ex vivo heart perfusion
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Blood; Cardiovascular; Evaluation; Ex-Vivo; Metabolism; Restoration; Resuscitation; Transplantation
Abstract
Heart transplantation is a viable therapeutic option for patients suffering end stage heart diseases. However there is a shortage of viable donor hearts due to size limitations and lack of brain death donors (the standard criteria for organ donation). One strategy to increase the donor pool is extending the criteria to include those donated after “cardiocirculatory determination of death” (DCD). However DCD donor hearts are considered suboptimal and need resuscitation.
Ex vivo heart perfusion (EVHP) has been proposed as a method for preservation, resuscitation, and evaluation of the donor heart, replacing conventional cold static storage. In EVHP, the heart is perfused and preserved in a beating status under normal physiological temperature and conditions. Unlike cold static storage, EVHP provides the opportunity of functional assessment and potential resuscitation and recovery of damaged DCD hearts before transplantation.
Due to the high metabolic demands of the working heart, EVHP requires the use of an oxygen carrier in the perfusate. We aim to study the effects of different oxygen carriers in the perfusate during EVHP resuscitation of hearts in the porcine model. Donor blood and bank blood are suboptimal due to immune and electrolyte factors. Cell-free hemoglobin-based oxygen carriers are an attractive option due to various immune and logistical advantages, but they can cause oxidative stress. Antioxidants and nitric oxide donors have been proposed as a solution to the problem, but they have yet to be studied systematically in the context of EVHP.
If our findings can be translated into a clinical protocol, the heart transplant donor pool could increase drastically, saving lives of many patients with end stage heart disease.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wu, Yilun
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~